One of the leading global biopharmaceutical institutions that develop drugs by transforming discoveries into novel treatments needed a flexible, scalable, and robust cloud platform to meet their future business requirements. Also, their legacy in-house system was not scalable to match future business requirements.
After assessing the client’s IT ecosystem, Intelliswift migrated the client’s legacy platform to the AWS cloud platform in a phased approach. The migration enabled client with high scalability and flexibility with reduced costs.
To know more about the success story, please fill the form.